Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9476680
[patent_doc_number] => 20140134143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'VECTORS AND METHODS FOR THE EFFICIENT GENERATION OF INTEGRATION/TRANSGENE-FREE INDUCED PLURIPOTENT STEM CELLS FROM PERIPHERAL BLOOD CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/157944
[patent_app_country] => US
[patent_app_date] => 2014-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16936
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14157944
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/157944 | VECTORS AND METHODS FOR THE EFFICIENT GENERATION OF INTEGRATION/TRANSGENE-FREE INDUCED PLURIPOTENT STEM CELLS FROM PERIPHERAL BLOOD CELLS | Jan 16, 2014 | Abandoned |
Array
(
[id] => 9616897
[patent_doc_number] => 20140206754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'METHODS AND MATERIALS FOR REDUCING THE SEVERITY OF VIRAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/156275
[patent_app_country] => US
[patent_app_date] => 2014-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13669
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14156275
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/156275 | Methods and materials for reducing the severity of viral infections | Jan 14, 2014 | Issued |
Array
(
[id] => 13026727
[patent_doc_number] => 10035980
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-31
[patent_title] => Extracellular matrix derived from stem cells and methods for production
[patent_app_type] => utility
[patent_app_number] => 14/760945
[patent_app_country] => US
[patent_app_date] => 2014-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 64
[patent_no_of_words] => 15973
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14760945
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/760945 | Extracellular matrix derived from stem cells and methods for production | Jan 13, 2014 | Issued |
Array
(
[id] => 9449448
[patent_doc_number] => 20140120618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'DELIVERY AGENT'
[patent_app_type] => utility
[patent_app_number] => 14/147028
[patent_app_country] => US
[patent_app_date] => 2014-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4508
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14147028
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/147028 | Delivery agent | Jan 2, 2014 | Issued |
Array
(
[id] => 9546842
[patent_doc_number] => 20140171491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-19
[patent_title] => 'INTRANASAL DELIVERY OF AAV ENCODING THERAPEUTIC ENZYMES TO THE CENTRAL NERVOUS SYSTEM FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/103597
[patent_app_country] => US
[patent_app_date] => 2013-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13753
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14103597
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/103597 | Intranasal delivery of AAV encoding therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases | Dec 10, 2013 | Issued |
Array
(
[id] => 10397455
[patent_doc_number] => 20150282462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'NOVEL INDUCIBLE ANIMAL MODELS OF STRESS BEHAVIOR'
[patent_app_type] => utility
[patent_app_number] => 14/650077
[patent_app_country] => US
[patent_app_date] => 2013-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17789
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14650077
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/650077 | Inducible animal models of stress behavior | Dec 4, 2013 | Issued |
Array
(
[id] => 9452159
[patent_doc_number] => 20140123329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'hnRNP A1 KNOCKOUT ANIMAL MODEL AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/092678
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6910
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14092678
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/092678 | hnRNP A1 knockout animal model and use thereof | Nov 26, 2013 | Issued |
Array
(
[id] => 9462863
[patent_doc_number] => 20140127290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'Microcapsules Encapsulating Living Cells'
[patent_app_type] => utility
[patent_app_number] => 14/075912
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20798
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075912
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/075912 | Microcapsules Encapsulating Living Cells | Nov 7, 2013 | Abandoned |
Array
(
[id] => 10422886
[patent_doc_number] => 20150307897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'NON-VIRAL VECTOR'
[patent_app_type] => utility
[patent_app_number] => 14/441713
[patent_app_country] => US
[patent_app_date] => 2013-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8410
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14441713
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/441713 | NON-VIRAL VECTOR | Nov 6, 2013 | Abandoned |
Array
(
[id] => 9330040
[patent_doc_number] => 20140056822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'DNA Dendrimers as Thermal Ablation Devices'
[patent_app_type] => utility
[patent_app_number] => 14/072892
[patent_app_country] => US
[patent_app_date] => 2013-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8102
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14072892
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/072892 | DNA Dendrimers as Thermal Ablation Devices | Nov 5, 2013 | Abandoned |
Array
(
[id] => 9476674
[patent_doc_number] => 20140134136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'COMPOSITIONS AND METHODS FOR AUDITORY THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/070763
[patent_app_country] => US
[patent_app_date] => 2013-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21247
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14070763
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/070763 | COMPOSITIONS AND METHODS FOR AUDITORY THERAPY | Nov 3, 2013 | Abandoned |
Array
(
[id] => 11421303
[patent_doc_number] => 20170029448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVEDDELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/107889
[patent_app_country] => US
[patent_app_date] => 2013-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13563
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15107889
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/107889 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | Oct 27, 2013 | Issued |
Array
(
[id] => 12170561
[patent_doc_number] => 09888674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-13
[patent_title] => 'Double knockout (GT/CMAH-KO) pigs, organs and tissues'
[patent_app_type] => utility
[patent_app_number] => 14/436963
[patent_app_country] => US
[patent_app_date] => 2013-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 27
[patent_no_of_words] => 13544
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436963
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/436963 | Double knockout (GT/CMAH-KO) pigs, organs and tissues | Oct 22, 2013 | Issued |
Array
(
[id] => 9295487
[patent_doc_number] => 20140039121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'Preparation of Polyphosphazene Microspheres'
[patent_app_type] => utility
[patent_app_number] => 14/048542
[patent_app_country] => US
[patent_app_date] => 2013-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3262
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048542
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/048542 | Preparation of Polyphosphazene Microspheres | Oct 7, 2013 | Abandoned |
Array
(
[id] => 11678556
[patent_doc_number] => 09677073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Hydroxylated polyamine derivatives as transfection reagents'
[patent_app_type] => utility
[patent_app_number] => 14/432327
[patent_app_country] => US
[patent_app_date] => 2013-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 19152
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14432327
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/432327 | Hydroxylated polyamine derivatives as transfection reagents | Oct 1, 2013 | Issued |
Array
(
[id] => 11678560
[patent_doc_number] => 09677078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Carboxylated polyamine derivatives as transfection reagents'
[patent_app_type] => utility
[patent_app_number] => 14/432361
[patent_app_country] => US
[patent_app_date] => 2013-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 21663
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14432361
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/432361 | Carboxylated polyamine derivatives as transfection reagents | Oct 1, 2013 | Issued |
Array
(
[id] => 10627641
[patent_doc_number] => 09345780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => 'Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components'
[patent_app_type] => utility
[patent_app_number] => 14/043682
[patent_app_country] => US
[patent_app_date] => 2013-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 74965
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14043682
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/043682 | Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components | Sep 30, 2013 | Issued |
Array
(
[id] => 9477163
[patent_doc_number] => 20140134626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'METHODS FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF PRIMARY AND METASTATIC BASAL-LIKE BREAST CANCER AND OTHER CANCER TYPES'
[patent_app_type] => utility
[patent_app_number] => 14/040034
[patent_app_country] => US
[patent_app_date] => 2013-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 27693
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14040034
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/040034 | Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer types | Sep 26, 2013 | Issued |
Array
(
[id] => 11053361
[patent_doc_number] => 20160250323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'Particles Comprising a Shell with RNA'
[patent_app_type] => utility
[patent_app_number] => 15/023052
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24189
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023052
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/023052 | Particles comprising a shell with RNA | Sep 25, 2013 | Issued |
Array
(
[id] => 9476771
[patent_doc_number] => 20140134234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'GENE OR DRUG DELIVERY SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/037892
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22194
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14037892
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/037892 | GENE OR DRUG DELIVERY SYSTEM | Sep 25, 2013 | Abandoned |